Ozempic can also protect the heart in people with diabetes and known heart disease Rybelsus (oral semaglutide) doesn't have FDA approval for heart protection
In the glucocorticoid-induced osteoporosis (GIOP) rat model, administration of liraglutide at a dose of ~ 53 nmol/kg/day did not result in significant weight loss [59]
Kanduri SR, Kovacic R, Skipper GR, Velez JCQ
Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors
Potential benefits of LLLT include: Increased hair density Improved hair thickness Reduced shedding Better scalp health LLLT devices may be used both in-clinic and at home as part of a comprehensive hair restoration plan
Mayo Clinic notes that tesamorelin should not be used by people with active cancer or a history of certain cancers, pituitary tumors or surgery, and that it must be avoided in pregnancy (Mayo Clinic precautions)